Companies / Privia Health Group, Inc. / Activity
Activity — Privia Health Group, Inc.
42 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $586.1K | -27K -4.56% | 555,443 0.43% of shares | medium |
| Mar 12, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $586.1K | -27K -4.21% | 609,181 0.48% of shares | medium |
| Mar 13, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $586.0K | -27K -4.47% | 581,952 0.46% of shares | medium |
| Mar 9, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $500.5K | -22K -5.68% | 363,879 0.28% of shares | medium |
| Mar 6, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $496.3K | -21K -5.26% | 385,794 0.30% of shares | medium |
| Mar 10, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $479.1K | -21K -6.14% | 322,698 0.25% of shares | medium |
| Mar 9, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $430.9K | -19K -5.20% | 343,795 0.27% of shares | medium |
| Feb 27, 2026 | Morris Matthew Shawn Director | Sell | Common Stock, par value $0.01 per share | $413.8K | -17K -19.53% | 68,188 0.05% of shares | medium |
| Feb 26, 2026 | Morris Matthew Shawn Director | Sell | Common Stock, par value $0.01 per share | $194.6K | -8K -10.25% | 68,188 0.05% of shares | medium |
| Feb 27, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $192.8K | -8K -4.26% | 172,909 0.14% of shares | medium |
| Mar 12, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $141.3K | -6K -2.69% | 233,369 0.18% of shares | medium |
| Mar 16, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $141.3K | -6K -2.82% | 220,413 0.17% of shares | medium |
| Mar 13, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $141.3K | -7K -2.81% | 226,804 0.18% of shares | medium |
| Feb 26, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $134.0K | -5K -3.01% | 172,909 0.14% of shares | medium |
| Mar 9, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $133.1K | -6K -3.48% | 161,903 0.13% of shares | medium |
| Mar 6, 2026 | Mountcastle David Executive | Sell | Common Stock, par value $0.01 per share | $119.8K | -5K -2.99% | 167,732 0.13% of shares | medium |
| Mar 9, 2026 | Fargis Edward C Executive | Sell | Common Stock, $0.01 par value per share | $113.0K | -5K -5.58% | 83,711 0.07% of shares | medium |
| Mar 6, 2026 | Fargis Edward C Executive | Sell | Common Stock, $0.01 par value per share | $101.7K | -4K -4.72% | 88,660 0.07% of shares | medium |
| Feb 27, 2026 | Morris Matthew Shawn Director | Exercise | Common Stock, par value $0.01 per share | $33.1K | +17K +24.27% | 84,738 0.07% of shares | low |
| Mar 9, 2026 | Mehrotra Parth CEO | Sell | Common Stock, $0.01 par value per share | $28.5K | -1K -0.34% | 362,660 0.28% of shares | low |
| Feb 26, 2026 | Morris Matthew Shawn Director | Exercise | Common Stock, par value $0.01 per share | $15.6K | +8K +11.42% | 75,976 0.06% of shares | low |
| Feb 27, 2026 | Mountcastle David Executive | Exercise | Common Stock, par value $0.01 per share | $15.4K | +8K +4.45% | 180,606 0.14% of shares | low |
| Feb 26, 2026 | Mountcastle David Executive | Exercise | Common Stock, par value $0.01 per share | $10.7K | +5K +3.10% | 178,270 0.14% of shares | low |
| May 20, 2026 | King David P Director | Grant | Common Stock, $0.01 par value per share | $0 | +8K +20.00% | 50,775 0.04% of shares | low |
| May 20, 2026 | Soistman Francis S Jr Director | Grant | Common Stock, $0.01 par value per share | $0 | +8K | 8,463 <0.01% of shares | low |
| May 20, 2026 | Cocozza Nancy G Director | Grant | Common Stock, $0.01 par value per share | $0 | +8K +24.64% | 42,814 0.03% of shares | low |
| May 20, 2026 | Berberian Lance Director | Grant | Common Stock, $0.01 par value per share | $0 | +8K +110.37% | 16,131 0.01% of shares | low |
| Mar 10, 2026 | Fargis Edward C Executive | Grant | Common Stock, $0.01 par value per share | $0 | +28K +33.77% | 111,979 0.09% of shares | low |
| Mar 11, 2026 | Mehrotra Parth CEO | Grant | Common Stock, $0.01 par value per share | $0 | +172K +37.05% | 635,944 0.50% of shares | low |
| Mar 10, 2026 | Mehrotra Parth CEO | Grant | Common Stock, $0.01 par value per share | $0 | +141K +43.80% | 464,040 0.36% of shares | low |
| Mar 11, 2026 | Mountcastle David Executive | Grant | Common Stock, par value $0.01 per share | $0 | +43K +21.59% | 239,822 0.19% of shares | low |
| Mar 10, 2026 | Mountcastle David Executive | Grant | Common Stock, par value $0.01 per share | $0 | +35K +21.82% | 197,238 0.15% of shares | low |
| Feb 27, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -572 -26.41% | 1,594 <0.01% of shares | low |
| Feb 27, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -3K -21.52% | 12,499 <0.01% of shares | low |
| Feb 27, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -3K -23.78% | 8,653 <0.01% of shares | low |
| Feb 27, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -998 -26.04% | 2,835 <0.01% of shares | low |
| Feb 26, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -700 -24.42% | 2,166 <0.01% of shares | low |
| Feb 26, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -2K -10.62% | 15,927 0.01% of shares | low |
| Feb 26, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -1K -8.83% | 11,352 <0.01% of shares | low |
| Feb 26, 2026 | Mountcastle David Executive | Exercise | Stock Option (Right to Purchase) | — | -2K -30.32% | 3,833 <0.01% of shares | low |
| Feb 27, 2026 | Morris Matthew Shawn Director | Exercise | Stock Option (Right to Purchase) | — | -17K -0.45% | 3,692,314 2.89% of shares | low |
| Feb 26, 2026 | Morris Matthew Shawn Director | Exercise | Stock Option (Right to Purchase) | — | -8K -0.21% | 3,708,864 2.90% of shares | low |